SOPHiA GENETICS (SOPH) EBT (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of EBT data on file, last reported at -$19.6 million in Q4 2025.

• For the quarter ending Q4 2025, EBT fell 34.6% year-over-year to -$19.6 million; the trailing twelve-month figure through Dec 2025 stood at -$77.5 million (down 26.47% YoY), and the FY2025 full-year result was -$77.5 million, down 26.47% from the prior year.
• EBT declined to -$19.6 million in Q4 2025, from -$19.4 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$12.5 million in Q1 2021 to a low of -$25.3 million in Q1 2022.
• A 5-year average of -$18.9 million and a median of -$19.5 million in 2025 frame the typical range for EBT.
• Across the five-year window, EBT jumped 99.8% in 2021 and slumped 102.15% in 2022, its largest moves.
• Tracing SOPH's EBT over 5 years: stood at -$21.9 million in 2021, then soared by 35.03% to -$14.2 million in 2022, then sank by 69.05% to -$24.1 million in 2023, then jumped by 39.54% to -$14.5 million in 2024, then slumped by 34.6% to -$19.6 million in 2025.
• Business Quant data shows SOPH's EBT at -$19.6 million in Q4 2025, -$19.4 million in Q3 2025, and -$21.7 million in Q2 2025.